Form 4: SCPharmaceuticals Director Acquires Stock Options
SEC Form 4 Filing
Minnie Baylor-Henry, a director of scPharmaceuticals Inc., acquired stock options for 19,750 shares of common stock on June 11, 2024.
Summary
- On June 11, 2024, Minnie Baylor-Henry, a director at scPharmaceuticals Inc., acquired stock options for 19,750 shares.
- The exercise price of these options is $4.11.
- The options vest fully on the earlier of June 11, 2025, or the next annual meeting of the Issuer's stockholders.
- The options expire on June 11, 2034.
- Following the transaction, Baylor-Henry directly owns derivative securities for 19,750 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock option grant to a company director, indicating a neutral sentiment.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence, as it shows a director's increased stake in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the stock option transaction. |
| 06/11/2025 | Earliest vesting date for the stock options. |
| 06/11/2034 | Expiration date for the stock options. |
| 06/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.